中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

美国胃肠病学会医学立场声明:非酒精性脂肪性肝病(2002年)

阅读次数:798
  • 分享到:

用微信扫码二维码

分享至好友和朋友圈

发布日期:2002-11-01
英文标题:American Gastroenterological Association Medical Position Statement: Nonalcoholic Fatty Liver Disease
来源:Gastroenterology, 2002, 123(5): 1702-1704
制定者:美国胃肠病协会(AGA),美国肝病研究学会(AASLD)

      nonalcoholic fatty liver disease (NAFLD) represents a spectrum of disorders characterized by predominantly macrovesicular hepatic steatosis that occur in individuals even in the absence of consumption of alcohol in amounts considered harmful to the liver. NAFLD is being increasingly recognized as a major cause of liver related morbidity and mortality. The likelihood of having NAFLD is directly proportional to body weight. Given the increasing prevalence of obesity in North America, NAFLD is an important public health problem. These considerations have led to the development of the technical review and practice guidelines statement, which are sponsored by the American Gastroenterological Association (AGA) and the American Association for the Study of Liver Diseases (AASLD).

  • 分享到:

用微信扫码二维码

分享至好友和朋友圈

阅读次数:798
  • 1 病毒性肝炎
    • 1.1 乙型肝炎
    • 1.2 丙型肝炎
    • 1.3 甲型肝炎
    • 1.4 戊型肝炎
    • 1.5 其他肝炎
  • 2 肝硬化及并发症
  • 3 酒精性肝病
  • 4 非酒精性脂肪性肝病
  • 5 肝衰竭/肝性脑病/人工肝
  • 6 肝肿瘤
  • 7 自身免疫性肝病
  • 8 药物性肝病
  • 9 肝移植
  • 10 其他肝病
    • 10.1 遗传及代谢性肝病
    • 10.2 胆汁淤积性肝病
    • 10.3 肝脏血管病
  • 11 一般肝病/肝脏检查
  • 12 胆道疾病
  • 13 胰腺疾病
  • 14 全身疾病与肝病/内镜
  • 15 肝胆胰疾病相关评分系统汇总